These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37863560)

  • 41. Inflammatory bowel disease of primary sclerosing cholangitis: a distinct entity?
    Nakazawa T; Naitoh I; Hayashi K; Sano H; Miyabe K; Shimizu S; Joh T
    World J Gastroenterol; 2014 Mar; 20(12):3245-54. PubMed ID: 24696608
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathology of dysplasia and cancer in inflammatory bowel disease.
    Mescoli C; Frego M; Rugge M
    Ann Ital Chir; 2011; 82(1):11-8. PubMed ID: 21657150
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathologist Experience and Concordance in the Diagnosis of Dysplasia in Long-standing Inflammatory Bowel Disease.
    Jimeno M; Domingo A; Salas I; Sánchez MR; González C; Salas C; Paúles MJ; Sanjuán X; Carballal S; Quintanilla I; Molist G; Cuatrecasas M; Pellisé M
    Am J Surg Pathol; 2020 Jul; 44(7):955-961. PubMed ID: 32235151
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Can dysplasia surveillance be better targeted in ulcerative colitis by using faecal calprotectin?
    Puolanne AM; Qadri S; Vesterinen T; Hiltunen S; Mustonen A; Kurki S; Kolho KL; Arola J; Färkkilä M
    Scand J Gastroenterol; 2022 Nov; 57(11):1304-1311. PubMed ID: 35697499
    [No Abstract]   [Full Text] [Related]  

  • 45. Colorectal dysplasia in chronic inflammatory bowel disease: pathology, clinical implications, and pathogenesis.
    Harpaz N; Polydorides AD
    Arch Pathol Lab Med; 2010 Jun; 134(6):876-95. PubMed ID: 20524866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease.
    Derikx LA; Kievit W; Drenth JP; de Jong DJ; Ponsioen CY; Oldenburg B; van der Meulen-de Jong AE; Dijkstra G; Grubben MJ; van Laarhoven CJ; Nagtegaal ID; Hoentjen F;
    Gastroenterology; 2014 Jan; 146(1):119-28.e1. PubMed ID: 24076060
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Loss of SATB2 Expression Is a Biomarker of Inflammatory Bowel Disease-associated Colorectal Dysplasia and Adenocarcinoma.
    Ma C; Henn P; Miller C; Herbst C; Hartman DJ; Pai RK
    Am J Surg Pathol; 2019 Oct; 43(10):1314-1322. PubMed ID: 31318711
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Significance of Sessile Serrated Polyps in Inflammatory Bowel Disease.
    Jackson WE; Achkar JP; Macaron C; Lee L; Liu X; Pai RK; Lopez R; Burke CA; Allende DS
    Inflamm Bowel Dis; 2016 Sep; 22(9):2213-20. PubMed ID: 27508509
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases.
    Itzkowitz SH; Harpaz N
    Gastroenterology; 2004 May; 126(6):1634-48. PubMed ID: 15168373
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Torres J; Pineton de Chambrun G; Itzkowitz S; Sachar DB; Colombel JF
    Aliment Pharmacol Ther; 2011 Sep; 34(5):497-508. PubMed ID: 21692821
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DALM, rest in peace: a pathologist's perspective on dysplasia in inflammatory bowel disease in the post-DALM era.
    Chiu K; Riddell RH; Schaeffer DF
    Mod Pathol; 2018 Aug; 31(8):1180-1190. PubMed ID: 29789648
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DNA content analysis of colorectal serrated lesions detects an aneuploid subset of inflammatory bowel disease-associated serrated epithelial change and traditional serrated adenomas.
    Choi WT; Wen KW; Rabinovitch PS; Huang D; Mattis AN; Gill RM
    Histopathology; 2018 Sep; 73(3):464-472. PubMed ID: 29772067
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
    de Vries AB; Janse M; Blokzijl H; Weersma RK
    World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endoscopic factors in the diagnosis of colorectal dysplasia in chronic inflammatory bowel disease.
    Toruner M; Harewood GC; Loftus EV; Sandborn WJ; Tremaine WJ; Faubion WA; Schroeder KW; Egan LJ
    Inflamm Bowel Dis; 2005 May; 11(5):428-34. PubMed ID: 15867581
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intestinal low-grade tubuloglandular adenocarcinoma in inflammatory bowel disease.
    Levi GS; Harpaz N
    Am J Surg Pathol; 2006 Aug; 30(8):1022-9. PubMed ID: 16861975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis.
    Ludwig K; Fassan M; Mescoli C; Pizzi M; Balistreri M; Albertoni L; Pucciarelli S; Scarpa M; Sturniolo GC; Angriman I; Rugge M
    Virchows Arch; 2013 Jan; 462(1):57-63. PubMed ID: 23224068
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Paradigm Shift in the Surveillance and Management of Dysplasia in Inflammatory Bowel Disease (West).
    Soetikno R; Kaltenbach T; McQuaid KR; Subramanian V; Kumar R; Barkun AN; Laine L
    Dig Endosc; 2016 Apr; 28(3):266-73. PubMed ID: 26866420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of ursodeoxycholic acid use on the risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis.
    Singh S; Khanna S; Pardi DS; Loftus EV; Talwalkar JA
    Inflamm Bowel Dis; 2013 Jul; 19(8):1631-8. PubMed ID: 23665966
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease.
    Shah SC; Glass J; Giustino G; Hove JRT; Castaneda D; Torres J; Kumar A; Elman J; Ullman TA; Itzkowitz SH
    Gut Liver; 2019 Jan; 13(1):54-61. PubMed ID: 30400722
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The histological diagnosis of dysplastic and neoplastic lesions in inflammatory bowel disease: a pathological perspective.
    Usaj S; Tarabar D; Cuk V; Cerovic S; Brajukovic G; Panisic M; Klem I; Eric Z
    Acta Chir Iugosl; 2004; 51(2):109-16. PubMed ID: 15771301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.